Your blog category
Lung cancer is a leading cause of cancer-related death worldwide, especially in patients with non-small cell lung cancer (NSCLC) that has epidermal growth factor receptor (EGFR) mutations. For patients fighting EGFR-mutant lung cancer, the road can be challenging. However, recent advancements in treatment options offer new hope. EGFR mutations occur in about 10-15% of NSCLC […]
Heart failure, a chronic condition that affects millions worldwide, poses a significant medical challenge, particularly as populations age. Among the various types of heart failure, heart failure with preserved ejection fraction (HFpEF) stands out due to the difficulties it presents in treatment. Unlike other forms, HFpEF has no effective medications that lower mortality rates, leaving
In the ever-evolving landscape of cancer treatment, immunotherapy has emerged as a beacon of hope, particularly in the fight against melanoma. Central to this advancement is the identification of novel biomarkers that can improve treatment strategies and patient outcomes. One such discovery is the existence of CRATERs, unique structures found on the surface of melanoma
CRATERs on Melanoma Cells: The Immune Hotspots That Could Revolutionize Cancer Therapy Read More »
Advancements in cancer treatment have highlighted the role of oral drug combinations for patients with advanced ER-positive breast cancer. ER-positive subtype comprises about 70% of all breast cancer cases. Innovative therapeutic strategies are being sought to improve patient outcomes, as current treatments often fall short. The phase 3 evERA Breast Cancer study revealed giredestrant’s impact:
